MedTrace Logo

Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring

NCT04906369 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-05-15

No results posted yet for this study

Summary

This study evaluates if blood tests can detect changes in disease status during treatment for stage IV breast cancer. Information from this study may help researchers learn more about metastatic breast cancer and how to optimize treatment.

Conditions

  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Breast Carcinoma
  • Prognostic Stage IV Breast Cancer AJCC v8

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

Sponsors & Collaborators

Principal Investigators

  • Brenda J. Ernst, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-16
Primary Completion
2027-12-30
Completion
2027-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04906369 on ClinicalTrials.gov